Apply now to join a UK trade mission to Japan this October. Meet potential partners, explore the growing bioeconomy, and attend the BioJapan conference.
The £7.5 million Longitude Prize on ALS is an international challenge prize to incentivize the use of AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND).
UK regulators can now apply for up to £1.6 million from the £5 million Engineering Biology Sandbox Fund Round 2 to run projects that drive pro-innovation regulatory reform in engineering biology.
Help shape the future of biopharma innovation by taking this 10-minute survey on biopharma entrepreneurship ecosystems and the support start-ups receive globally.
LifeArc's newly launched B-SMArT antibody discovery platform offers collaborators a clinically validated transgenic mouse model (Kymab/Sanofi) and advanced single B-cell selection technologies (Beacon and FACS) to generate fully human antibodies ready for in vivo testing.
This nationwide initiative is calling on companies, teams, and individuals to commit to a fitness challenge while raising vital funds for translational cancer research—helping life-saving innovations move from the lab to patients faster.
